Pills made from poop cure serious gut infections

October 3, 2013 by Marilynn Marchione
Dr. Thomas Louie, an infectious disease specialist at the University of Calgary, holds a container of stool pills in triple-coated gel capsules in his lab in Calgary, Alberta, Canada on Thursday, Sept. 26, 2013. Half a million Americans get Clostridium difficile, or C-diff, infections each year, and about 14,000 die. A very potent and pricey antibiotic can kill C-diff but also destroys good bacteria that live in the gut, leaving it more susceptible to future infections. Recently, studies have shown that fecal transplants - giving infected people stool from a healthy donor - can restore that balance. (AP Photo/The Canadian Press, Jeff McIntosh)

Doctors have found a way to put healthy people's poop into pills that can cure serious gut infections—a less yucky way to do "fecal transplants." Canadian researchers tried this on 27 patients and cured them all after strong antibiotics failed to help.

It's a disgusting topic but a serious problem. Half a million Americans get Clostridium difficile, or C-diff, infections each year, and about 14,000 die. The germ causes nausea, cramping and diarrhea so bad it is often disabling. A very potent and pricey antibiotic can kill C-diff but also destroys good that live in the gut, leaving it more susceptible to future infections.

Recently, studies have shown that fecal transplants—giving infected people stool from a healthy donor—can restore that balance. But they're given through expensive, invasive procedures like colonoscopies or throat tubes. Doctors also have tried giving the stool through enemas but the doesn't always take hold.

There even are YouTube videos on how to do a similar treatment at home via an enema. A study in a medical journal of a small number of these "do-it-yourself" cases suggests the approach is safe and effective.

Dr. Thomas Louie, an infectious disease specialist at the University of Calgary, devised a better way—a one-time treatment custom-made for each patient.

Donor stool, usually from a relative, is processed in the lab to take out food and extract the bacteria and clean it. It is packed into triple-coated gel capsules so they won't dissolve until they reach the intestines.

"There's no stool left—just stool bugs. These people are not eating poop," and there are no smelly burps because the contents aren't released until they're well past the stomach, Louie said.

Days before starting the treatment, patients are given an antibiotic to kill the C-diff. On the morning of the treatment, they have an enema so "the new bacteria coming in have a clean slate," Louie said.

Dr. Thomas Louie, an infectious disease specialist at the University of Calgary, prepares stool pills in his lab in Calgary, Alberta, Canada on Thursday, Sept. 26, 2013. Donor stool, usually from a relative, is processed in the lab to extract the bacteria and clean it. It is packed into triple-coated gel capsules so they won't dissolve until they reach the intestines. (AP Photo/The Canadian Press, Jeff McIntosh)

It takes 24 to 34 capsules to fit the bacteria needed for a treatment, and patients down them in one sitting. The make their way to the colon and seed it with the normal variety of bacteria.

Louie described 27 patients treated this way on Thursday at IDWeek, an infectious diseases conference in San Francisco. All had suffered at least four C-diff infections and relapses, but none had a recurrence after taking the poop pills.

Margaret Corbin, 69, a retired nurse's aide from Calgary, told of the misery of C-diff.

"It lasted for two years. It was horrible. I thought I was dying. I couldn't eat. Every time I ate anything or drank water I was into the bathroom," she said. "I never went anywhere, I stayed home all the time."

With her daughter as the donor, she took pills made by Louie two years ago, and "I've been perfectly fine since," Corbin said.

Dr. Curtis Donskey of the Cleveland Veterans Affairs Medical Center, who has done fecal transplants through colonoscopies, praised the work.

"The approach that Dr. Louie has is completely novel—no one else has done this," he said. "I am optimistic that this type of preparation will make these procedures much easier for patients and for physicians."

Dr. Thomas Louie, right, an infectious disease specialist at the University of Calgary, administers fecal transplant pills to a patient in his lab in Calgary, Alberta, Canada on Thursday, Sept. 26, 2013. "There's no stool left - just stool bugs. These people are not eating poop," and there are no smelly burps because the contents aren't released until they're well past the stomach, Louie said. (AP Photo/The Canadian Press, Jeff McIntosh)

The treatment now must be made fresh for each patient so the pills don't start to dissolve at room temperature, because their water content would break down the gel coating. Minnesota doctors are testing freezing stool, which doesn't kill the bacteria, so it could be stored and shipped anywhere a patient needed it.

"You could have a universal donor in Minnesota provide a transplant for someone in Florida. That's where we're heading," Donskey said.

Other researchers are trying to find which bacteria most help fight off C-diff. Those might be grown in a lab dish and given to patients rather than the whole spectrum of bacteria in stool.

The hope is "we could administer that as a probiotic in a pill form," Donskey said.

Louie sees potential for the poop pills for other people with out-of-whack , such as hospitalized patients vulnerable to antibiotic-resistant germs.

"This approach, to me, has wide application in medicine," he said. "So it's not just about C-diff."

Explore further: Johns Hopkins Children's Center begins fecal transplants in children with a type of drug-resistant diarrhea

Related Stories

Johns Hopkins Children's Center begins fecal transplants in children with a type of drug-resistant diarrhea

July 31, 2013
Call it therapeutic poop, if you will, but the best hope yet for an effective treatment of childhood infections with the drug-resistant bacterium C. difficile may come straight from the gut, according to recent research.

Synthetic 'poop' can cure C. difficile infection, study finds

January 8, 2013
A synthetic "poop" developed at the University of Guelph can cure nasty gastrointestinal infections caused by Clostridium difficile, a toxin-producing bacterium.

Using human stool to treat C. diff is safe, effective

October 19, 2012
A novel therapy that uses donated human stool to treat the deadly and contagious C.diff infection is safe and highly effective, according to a Henry Ford Hospital study.

Bacterial infection's spread occurs beyond health care settings, study finds

September 25, 2013
(HealthDay)—A new British study raises questions about the transmission of Clostridium difficile, a bacteria that causes life-threatening diarrhea in people who have recently been on antibiotics.

Synthetic stool a prospective treatment for C. difficile

April 30, 2012
A synthetic mixture of intestinal bacteria could one day replace stool transplants as a treatment for Clostridium difficile (C. difficile). C. difficile is a toxin-producing bacteria that can overpopulate the colon when antibiotics ...

Recommended for you

Finish your antibiotics course? Maybe not, experts say

July 27, 2017
British disease experts on Thursday suggested doing away with the "incorrect" advice to always finish a course of antibiotics, saying the approach was fuelling the spread of drug resistance.

Co-infection with two common gut pathogens worsens malnutrition in mice

July 27, 2017
Two gut pathogens commonly found in malnourished children combine to worsen malnutrition and impair growth in laboratory mice, according to new research published in PLOS Pathogens.

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

July 26, 2017
A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for giant cell arteritis, the ...

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.